Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lingbao Gold Group Company Ltd | LI9 | Oct 4, 2024 | 0.35 | +4.85 |
Link Mobility Group Holding | L1N | Oct 4, 2024 | 1.92 | -0.42 |
Link Real Estate Investment Trust Units | L5R | Oct 4, 2024 | 4.60 | +1.69 |
Linklogis Inc | 0NY | Oct 4, 2024 | 0.21 | +4.95 |
Linmon Media Limited | 8MN | Oct 4, 2024 | 0.51 | 0.00 |
Lintec Corporation | 57T | Oct 4, 2024 | 21.00 | +1.94 |
LINUS DIGITAL FINANCE AG | LDF | Oct 4, 2024 | 1.61 | 0.00 |
Lion Copper and Gold Corp | QR20 | Oct 4, 2024 | 0.04 | 0.00 |
Lion Corporation | LOC | Oct 4, 2024 | 9.65 | 0.00 |
Lion E-Mobility AG | LMIA | Oct 4, 2024 | 0.61 | -20.13 |
Lion Electric Co (The) | 70U | Oct 4, 2024 | 0.51 | +0.50 |
Lion One Metals Ltd | LY1 | Oct 4, 2024 | 0.21 | +2.93 |
LION ROCK RES.INC. | KGB | Oct 4, 2024 | 0.11 | 0.00 |
Lions Gate Entertainment Corp. | LGNB | Oct 4, 2024 | 6.10 | -1.61 |
Lions Gate Entertainment Corporation Class A Voting Shares | LGNA | Oct 4, 2024 | 6.94 | -1.35 |
Lipidor | L7R | Oct 4, 2024 | 0.00 | -95.45 |
Lipigon Pharmaceuticals | 9RP | Oct 4, 2024 | 0.01 | -16.09 |
LIPPO | LIP | Oct 4, 2024 | 0.08 | +1.23 |
Lippo Malls Indonesia Retail Trust Units | 3HJ | Oct 4, 2024 | 0.01 | -2.73 |
Liquidia Corporation | LT4 | Oct 4, 2024 | 9.27 | +3.40 |
Liquidity Services, Inc. | L1S | Oct 4, 2024 | 20.00 | +2.04 |
Lisi Group | LI3 | Oct 4, 2024 | 25.60 | -1.73 |
LITALICO INC. | 9N0 | Oct 4, 2024 | 6.95 | 0.00 |
Literacy Capital Plc | 26W | Oct 4, 2024 | 5.65 | -0.88 |
Lithia Motors, Inc. | LMO | Oct 4, 2024 | 274.00 | -1.44 |
Lithium Americas (Argentina) | WUC0 | Oct 4, 2024 | 2.87 | +4.74 |
Lithium Australia NL | 3MW | Oct 4, 2024 | 0.01 | +26.83 |
Lithium Chile Inc | KC3 | Oct 4, 2024 | 0.38 | +7.37 |
Lithium Energi Exploration Inc | L09 | Oct 4, 2024 | 0.02 | +25.00 |
LITHIUM IONIC CORP. | H3N | Oct 4, 2024 | 0.56 | -1.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.